Hispanic clinical trial participation remains critically low despite being one of the fastest-growing demographic groups in the U.S. This gap not only limits the generalizability of research findings, but also deepens existing healthcare disparities.
Hispanic individuals make up nearly 19% of the U.S. population yet represent a small fraction of clinical trial participants. When research lacks diverse representation, treatments developed may not work equally well across all populations. Closing this gap is essential for advancing equitable healthcare outcomes.
In this white paper, we explore real perspectives from Hispanic patients across two different healthcare settings, examining their awareness of clinical trials, the barriers they face, and what factors influence their willingness to participate. Key topics include:
- Language accessibility and communication barriers
- Financial constraints and logistical challenges
- Trust, cultural representation and community engagement
- Actionable strategies for more inclusive clinical research
Enter your email to download the full report on improving Hispanic engagement in clinical research. The white paper will be sent to your inbox.